# DESCRIPTION

## BACKGROUND

- motivate cancer treatment
- highlight limitations of existing therapies

## SUMMARY

- introduce dendritic cell-based cancer therapy
- describe tumor membrane vesicle composition
- outline methods of treating cancer

## DETAILED DESCRIPTION

- define scope of disclosure
- explain terminology usage
- incorporate publications and patents by reference
- define "embodiment"
- describe techniques used in embodiments
- define "subject"
- define "treat" and "treating"
- explain "combination with" administration
- define "cancer"
- describe cancer types
- define "chemotherapy agent"
- list examples of chemotherapy agents
- define "nucleic acid"
- explain "encoding"
- define "polypeptide", "peptide", and "protein"
- define "heterologous" nucleic acid sequence or peptide sequence
- define "recombinant" nucleic acid molecule and protein
- define "vector" or "expression vector"
- describe protein "expression systems"

### Tumor Membrane Vesicles (TMVs)

- define TMVs
- describe TMV composition
- motivate TMV use in cancer treatment
- introduce GPI-anchored immunostimulatory molecules
- describe protein transfer method
- incorporate GPI-anchored proteins onto TMVs
- describe TMV-based vaccine immunotherapy approach
- motivate dendritic cell pulsing with cytokine-adjuvanted TMVs
- describe DC vaccine platform
- detail TMV uptake and DC activation
- describe tumor growth inhibition and survival improvement
- detail metastasis reduction and immune cell infiltration
- describe immunogenicity and uptake of TMVs by DCs
- introduce fusion proteins with cytokine surface protein
- describe incorporation of fusion proteins into TMVs
- detail cancer antigen selection
- describe anchoring of antigen molecule onto TMV membrane
- detail TMV extraction and purification methods
- describe sonication and extrusion of TMVs
- motivate treatment of cancer with DCs pulsed with TMVs
- describe administration of DCs pulsed with TMVs
- introduce combination therapy with immunotherapeutic agents
- describe adjuvant administration

### TMV Preparation, Characterization, and GPI-ISM Incorporation

- prepare and characterize TMVs with GPI-ISMs

### TMVs Containing the Tumor Antigen HER2 and Protein Transferred GPI-ISMs on Their Surface

- characterize TMVs with HER2 and GPI-ISMs

### Uptake of TMVs by DCs is Potentiated by GPI-ISMs

- test DC uptake of TMVs with GPI-ISMs
- analyze DC uptake and GPI-ISM incorporation

### DC Vaccine Therapy Reduces Tumor Growth

- test DC vaccine therapy in HER2 positive murine model

### DC Vaccine Inhibits 4T1 Tumor Growth, Reduces Lung Metastasis, and Improved Immune Profile of Tumors

- test DC vaccine therapy in 4T1 TNBC model

### Bone Marrow-Derived Dendritic Cell (BMDC) Production

- generate and culture BMDCs

### 4T1 Lung Metastasis Assay

- quantify lung metastasis in 4T1 tumor-bearing mice

